Medterra Pain Relief 500mg Hemp Menthol Cream

Description

This topical cream contains 500 mg of hemp and menthol, formulated to provide pain relief. The product is presented in a 1.7 fl. oz. (50.3 mL) container. The combination of menthol, hemp, and other botanical ingredients is designed to offer rapid relief for conditions such as arthritis and joint pain. The formulation emphasizes trusted transparency in its ingredient sourcing and efficacy.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with sore muscles and joints. Specifically, it is effective for conditions such as arthritis, backache, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to apply the cream to the affected areas daily, as needed. It is recommended that patients consult with a physician to determine the optimal usage tailored to their specific condition.

Contraindications

Use of this product is contraindicated in the following situations:

Contact with the eyes or mucous membranes should be avoided due to the potential for irritation. Application to wounds or damaged skin is contraindicated to prevent adverse reactions. The product should not be used concurrently with other ointments, creams, sprays, or liniments, as this may lead to unpredictable effects. Application to irritated skin or in cases where excessive irritation develops is also contraindicated. Bandaging the area after application is not recommended, as it may exacerbate irritation. Additionally, the use of heating pads or devices in conjunction with this product is contraindicated due to the risk of increased irritation or adverse effects.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes or mucous membranes. The product should not be applied to wounds or damaged skin, nor should it be used in conjunction with other ointments, creams, sprays, or liniments. Application to irritated skin is contraindicated, and if excessive irritation develops, use should be discontinued. Bandaging the area after application is not recommended.

Healthcare professionals should advise patients to wash their hands thoroughly with cool water after using the product. Additionally, it should not be used in combination with heating pads or devices, and proper storage in a cool, dry place is essential to maintain product integrity.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients are advised to discontinue use and consult a healthcare provider if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur.

Side Effects

For external use only. Patients should discontinue use and consult a doctor if conditions worsen, if symptoms persist for more than 7 days, or if symptoms clear up and then recur. Additionally, individuals with sensitive skin are advised to seek medical advice before using this product.

Drug Interactions

Co-administration of this medication with other topical formulations, including ointments, creams, sprays, or liniments, is contraindicated. The use of multiple topical agents may lead to altered absorption or efficacy of the treatment, potentially resulting in adverse effects or diminished therapeutic outcomes.

There are no specific interactions identified with laboratory tests associated with this medication. Therefore, routine monitoring of laboratory parameters is not required in the context of drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Medterra Pain Relief 500mg Hemp Menthol Cream (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should consult a healthcare professional prior to using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to seek medical advice to weigh the benefits and risks before initiating treatment.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be considered as part of standard clinical practice.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, the use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent. Consultation with a poison control center or a medical toxicologist is recommended for guidance on specific management strategies tailored to the situation.

Overall, vigilance and prompt intervention are critical in managing any suspected overdose scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is accidentally ingested. Patients should be informed that if their condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then recur, they should consult their healthcare provider.

It is important to instruct patients to avoid contact with the eyes or mucous membranes and to refrain from applying the product to wounds or damaged skin. Patients should be cautioned against using the product in conjunction with other ointments, creams, sprays, or liniments, as well as on irritated skin or if excessive irritation develops. Additionally, patients should be advised not to bandage the area after application.

Healthcare providers should emphasize the importance of washing hands with cool water after using the product. Patients should also be informed not to use the product with heating pads or devices. It is recommended that the product be stored in a cool, dry place.

Finally, healthcare providers should encourage patients to consult with their doctor before use if they have sensitive skin, ensuring that they are aware of any potential risks associated with the product.

Storage and Handling

The product is supplied in a configuration that ensures optimal preservation of its integrity. It is essential to store the product in a cool, dry place to maintain its efficacy. Care should be taken to keep the product away from excessive heat and open flame, as these conditions may compromise its quality and safety. Proper storage conditions are crucial for ensuring the product remains effective throughout its shelf life.

Additional Clinical Information

Patients are advised to apply the cream to affected areas daily as needed, with consultation from a physician recommended for optimal usage. No further information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Medterra Pain Relief 500mg Hemp Menthol Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)